CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
We are very excited to launch our new website! Please take a few moments to click around and explore...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...